These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 28335992)

  • 21. Varicella zoster virus infection: clinical features, molecular pathogenesis of disease, and latency.
    Mueller NH; Gilden DH; Cohrs RJ; Mahalingam R; Nagel MA
    Neurol Clin; 2008 Aug; 26(3):675-97, viii. PubMed ID: 18657721
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Varicella zoster virus vasculopathy: clinical features and pathogenesis.
    Nagel MA
    J Neurovirol; 2014 Apr; 20(2):157-63. PubMed ID: 23918503
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neurological complications of varicella zoster virus reactivation.
    Nagel MA; Gilden D
    Curr Opin Neurol; 2014 Jun; 27(3):356-60. PubMed ID: 24792344
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Manipulation of the Innate Immune Response by Varicella Zoster Virus.
    Gerada C; Campbell TM; Kennedy JJ; McSharry BP; Steain M; Slobedman B; Abendroth A
    Front Immunol; 2020; 11():1. PubMed ID: 32038653
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Varicella zoster virus infection.
    Gershon AA; Breuer J; Cohen JI; Cohrs RJ; Gershon MD; Gilden D; Grose C; Hambleton S; Kennedy PG; Oxman MN; Seward JF; Yamanishi K
    Nat Rev Dis Primers; 2015 Jul; 1():15016. PubMed ID: 27188665
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Varicella-Zoster Virus Vasculopathy: The Growing Association Between Herpes Zoster and Strokes.
    Powell DR; Patel S; Franco-Paredes C
    Am J Med Sci; 2015 Sep; 350(3):243-5. PubMed ID: 25211583
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neurovirulence of varicella and the live attenuated varicella vaccine virus.
    Horien C; Grose C
    Semin Pediatr Neurol; 2012 Sep; 19(3):124-9. PubMed ID: 22889542
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Varicella-zoster virus: a re-emerging infection.
    LaGuardia JJ; Gilden DH
    J Investig Dermatol Symp Proc; 2001 Dec; 6(3):183-7. PubMed ID: 11924825
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Upregulation of CXCL10 in human dorsal root ganglia during experimental and natural varicella-zoster virus infection.
    Steain M; Gowrishankar K; Rodriguez M; Slobedman B; Abendroth A
    J Virol; 2011 Jan; 85(1):626-31. PubMed ID: 20980518
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular and therapeutic aspects of varicella-zoster virus infection.
    Quinlivan M; Breuer J
    Expert Rev Mol Med; 2005 Aug; 7(15):1-24. PubMed ID: 16098235
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular studies of Varicella zoster virus.
    Quinlivan M; Breuer J
    Rev Med Virol; 2006; 16(4):225-50. PubMed ID: 16791838
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Varicella-zoster virus T cell tropism and the pathogenesis of skin infection.
    Arvin AM; Moffat JF; Sommer M; Oliver S; Che X; Vleck S; Zerboni L; Ku CC
    Curr Top Microbiol Immunol; 2010; 342():189-209. PubMed ID: 20397071
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Varicella-Zoster Virus Infection of Neurons Derived from Neural Stem Cells.
    Kennedy PGE; Mogensen TH
    Viruses; 2021 Mar; 13(3):. PubMed ID: 33804210
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of Varicella-Zoster Virus in Temporal Arteries Biopsy Positive and Negative for Giant Cell Arteritis.
    Nagel MA; White T; Khmeleva N; Rempel A; Boyer PJ; Bennett JL; Haller A; Lear-Kaul K; Kandasmy B; Amato M; Wood E; Durairaj V; Fogt F; Tamhankar MA; Grossniklaus HE; Poppiti RJ; Bockelman B; Keyvani K; Pollak L; Mendlovic S; Fowkes M; Eberhart CG; Buttmann M; Toyka KV; Meyer-ter-Vehn T; Petursdottir V; Gilden D
    JAMA Neurol; 2015 Nov; 72(11):1281-7. PubMed ID: 26349037
    [TBL] [Abstract][Full Text] [Related]  

  • 35. VZV T cell-mediated immunity.
    Weinberg A; Levin MJ
    Curr Top Microbiol Immunol; 2010; 342():341-57. PubMed ID: 20473790
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recent Issues in Varicella-Zoster Virus Latency.
    Kennedy PGE; Mogensen TH; Cohrs RJ
    Viruses; 2021 Oct; 13(10):. PubMed ID: 34696448
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The varicella zoster virus vasculopathies: clinical, CSF, imaging, and virologic features.
    Nagel MA; Cohrs RJ; Mahalingam R; Wellish MC; Forghani B; Schiller A; Safdieh JE; Kamenkovich E; Ostrow LW; Levy M; Greenberg B; Russman AN; Katzan I; Gardner CJ; Häusler M; Nau R; Saraya T; Wada H; Goto H; de Martino M; Ueno M; Brown WD; Terborg C; Gilden DH
    Neurology; 2008 Mar; 70(11):853-60. PubMed ID: 18332343
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chronic Headache and Cerebral Venous Sinus Thrombosis Due to Varicella Zoster Virus Infection: A Case Report and Review of the Literature.
    Alamlih L; Abdulgayoom M; Menik Arachchige SN; Shah MH; Zahid M
    Am J Case Rep; 2021 Mar; 22():e927699. PubMed ID: 33727523
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Varicella zoster virus: natural history and current therapies of varicella and herpes zoster.
    Breuer J; Whitley R
    Herpes; 2007 Sep; 14 Suppl 2():25-9. PubMed ID: 17939892
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The global epidemiology of herpes zoster.
    Yawn BP; Gilden D
    Neurology; 2013 Sep; 81(10):928-30. PubMed ID: 23999562
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.